Saito Hirohisa, Kato Atsushi, Matsumoto Kenji
Department of Allergy and Immunology, National Research Institute for Child Health and Development.
Nihon Rinsho. 2009 Nov;67(11):2083-7.
Mast cells play a central role in IgE-mediated immediate-type allergic reaction and contribute to the late-phase allergic inflammation by releasing a variety of cytokines and chemokines. These cells also have a substantial effect on tissue remodeling, especially on airway smooth muscle hypertrophy and mucus hypersecretion by releasing proteases and growth factors such as tryptase and amphiregulin. The activation of mast cells in vitro is partially inhibited by the pretreatment with corticosteroid or tacrolimus through inhibition of NF-kappaB and NF-AT, respectively, and is profoundly blocked by the simultaneous treatment of the two drugs. Pharmaceutical development of safer drugs is expected to treat mast cell-mediated allergic disorders.
肥大细胞在IgE介导的速发型过敏反应中起核心作用,并通过释放多种细胞因子和趋化因子促进迟发型过敏炎症。这些细胞还通过释放蛋白酶和生长因子(如类胰蛋白酶和双调蛋白)对组织重塑产生重大影响,尤其是对气道平滑肌肥大和黏液分泌过多。肥大细胞在体外的激活分别通过抑制核因子κB和活化T细胞核因子被皮质类固醇或他克莫司预处理部分抑制,并被两种药物同时处理完全阻断。有望开发出更安全的药物来治疗肥大细胞介导的过敏性疾病。